You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.

Skip to main content Skip to search

Guidelines & Advice

About Guidelines Email Guidelines Team

Lung Cancer

These guidelines and other documents provide advice for non-small cell lung cancer and small cell lung cancer.

Displaying Guidelines

45 Items

The Role of High Dose Rate Brachytherapy in the Palliation of Symptom in Patients with Non-Small Cell Lung Cancer

Document Status: Current
ID: 7-16
Version: 4

Dec 2022

The Role of IMRT in Lung Cancer

Document Status: Archived
ID: 21-3-5

Nov 2010

The Role of Photodynamic Therapy (PDT) in Patients with Non-Small Cell Lung Cancer

Document Status: Archived
ID: 7-15
Version: 2

Jan 2014

The Use of Systemic Treatment in the Maintenance of Patients with Non-Small Cell Lung Cancer

Document Status: In-Review
ID: 7-22

Aug 2015

Therapy for Stage IV Non–Small-Cell Lung Cancer With Driver Alterations: American Society of Clinical Oncology (ASCO) and Ontario Health (Cancer Care Ontario) Joint Guideline Update

Document Status: Current
ID: 7-A-2018-3

Feb 2021

Therapy for Stage IV Non–Small-Cell Lung Cancer Without Driver Alterations: ASCO and OH (CCO) Joint Guideline Update

Document Status: Current
ID: 7-A-2018-2
Version: N/A

Jan 2020

Thoracic Surgical Oncology Standards

Document Status: Current
ID: 17-1
Version: 2

Mar 2015

Use of Preoperative Chemotherapy With or Without Postoperative Radiotherapy in Technically Resectable Stage IIIA Non-Small Cell Lung Cancer

Document Status: Archived
ID: 7-4
Version: 2

Dec 2017

Use of the Epidermal Growth Factor Receptor Inhibitors Gefitinib (Iressa®), Erlotinib (Tarceva®), Afatinib, Dacomitinib or Icotinib in the Treatment of Non–SmallCell Lung Cancer: A Clinical Practice Guideline

Document Status: In-Review
ID: 7-9
Version: 2

Apr 2014